KK
ABBV icon

KLP Kapitalforvaltning’s AbbVie ABBV Stock Holding History

KLP Kapitalforvaltning’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211M Buy
836,672
+38,300
+5% +$8.24M 0.68% 24
2026
Q1 		$174M Buy
798,372
+24,300
+3% +$5.39M 0.68% 18
2025
Q4 		$177M Buy
774,072
+29,600
+4% +$6.74M 0.68% 18
2025
Q3 		$172M Buy
744,472
+8,600
+1% +$1.75M 0.68% 19
2025
Q2 		$137M Buy
735,872
+19,100
+3% +$3.55M 0.59% 22
2025
Q1 		$150M Buy
716,772
+13,600
+2% +$2.64M 0.74% 20
2024
Q4 		$125M Buy
+703,172
New +$129M 0.59% 23

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

KLP Kapitalforvaltning's ABBV Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its AbbVie (ABBV) stake by 4.8% in Q2 2026, buying an estimated $8.24M and bringing the position to 836,672 shares worth $211M. The position accounts for 0.68% of the portfolio, ranked #24.

KLP Kapitalforvaltning first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • KLP Kapitalforvaltning held 836,672 shares of AbbVie worth $211M as of Q2 2026.
  • KLP Kapitalforvaltning bought 38,300 AbbVie shares in Q2 2026, an estimated $8.24M.
  • AbbVie made up 0.68% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #24 holding.
  • KLP Kapitalforvaltning first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.